Pa. Appeals Court Upholds GSK Win In Paxil Pregnancy Suit

Law360, Philadelphia (December 2, 2013, 2:32 PM EST) -- The Pennsylvania Superior Court said Wednesday that there was no evidence that GlaxoSmithKline PLC had fraudulently concealed information from a woman about the risk of taking its antidepressant drug Paxil while pregnant and agreed that her claims against the drugmaker were barred by a two-year statute of limitations.

A three-judge panel shot down arguments that wrongful death claims brought in 2007 by plaintiff Joanne Thomas, who says she was forced to abort her baby in 2001 after it developed congenital heart defects in utero, should have been tolled until 2005, when GSK changed the warning label for Paxil to properly indicate...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!